Rare diseases
Investigational molecules
Locations
20 Avenue Du Docteur Rene Laennec, 68100 Mulhouse, France
Groupe Hospitalier De La Region De Mulhouse Et Sud Alsace in Mulhouse, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage IV, Acute myeloid leukaemia, Chronic kidney disease, and other specialisations. This site conducts important research.
The department is conducting research on Mycobacterium xenopi pulmonary infection, aiming to improve treatment outcomes through innovative inhaled antibiotic approaches.
These studies are carried out at Groupe Hospitalier De La Region De Mulhouse Et Sud Alsace, contributing to better management of difficult‑to‑treat bacterial lung infections.
Researchers are exploring new therapeutic combinations for myelofibrosis, focusing on disease control in patients who have not received prior treatment.
The work at this Mulhouse hospital aims to expand options for patients with advanced hematologic disorders.
The pneumology unit is investigating an oral agent for Diabetic Peripheral Neuropathic Pain, with the goal of reducing pain intensity and improving daily function.
This research provides hope for individuals living with chronic neuropathic pain associated with diabetes.
A study targeting Systemic Lupus Erythematosus is evaluating a novel oral therapy designed to modulate immune activity and lower disease activity scores.
Conducted at the Mulhouse research site, this work seeks to broaden therapeutic choices for patients with autoimmune disease.
Clinical trials currently enrolling participants at this site.
A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
FranceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
FranceStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
FranceA Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment
FranceStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
FranceStudy of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment
FranceStudy of felzartamab compared to placebo in adults with IgA nephropathy
FranceStudy of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care
FranceStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
FranceStudy on Digital Monitoring of Symptoms in Patients with Advanced Kidney Cancer Treated with Cabozantinib and Nivolumab
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
